
New data reveals that while antibiotic prescriptions have fallen across England in the last three years, struggling GP practices in …
Two companies at the centre of the UK’s R&D efforts to tackle the growing threat of resistance to antibiotics are expanding …
NICE has published guidance to help health care professionals promote and monitor the sensible use of antibiotics – and support …

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …

A new, not-for-profit coalition has launched with a mission to tackle antimicrobial resistance (AMR) and what it sees as the …

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

NICE are asking UK doctors to spy on their colleagues in order to help tackle the growing threat of antimicrobial …

Roche is to collaborate with Japan-based pharma firm Meiji and Canadian Fedora – two companies specialising in the production of …

Cempra Pharmaceuticals has become the first company to publish results from a Phase III study completed under FDA regulations governing …

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …

Antibiotic-resistant bacteria will kill an extra 10 million people a year by 2050 if the problem is not tackled soon, …

Merck has purchased US antibiotics maker Cubist in a deal valued at $9.5 billion. The acquisition values Cubist at around …
NICE guidelines say GPs should use point of care blood tests to assess which patients to prescribe antibiotics for bacterial …

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

People in the UK believe antibiotic resistance is second only to terrorism among threats to the public, according to a …